Insight and attitudes towards medication among inpatients with chronic schizophrenia in the US and China

Social Psychiatry and Psychiatric Epidemiology

Volumn 49, Issue 7, 2014, Pages 1063-1070

  Mohamed, Somaia ^a   Rosenheck, Robert ^a   He, Hongbo ^b   Yuping, Ning ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Guangzhou Psychiatric Hospital   (China)

Author keywords

Insight; Medication attitude; Quality of life; Schizophrenia; Social functioning

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; ATTITUDE TO HEALTH; CHINA; CHRONIC DISEASE; ETHNOLOGY; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MALE; MENTAL HOSPITAL; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; QUESTIONNAIRE; SCHIZOPHRENIA; SOCIAL STIGMA; TREATMENT OUTCOME; UNITED STATES;

ANTIPSYCHOTIC AGENTS; CHINA; CHRONIC DISEASE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HOSPITALIZATION; HOSPITALS, PSYCHIATRIC; HUMANS; INPATIENTS; MALE; QUESTIONNAIRES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL STIGMA; TREATMENT OUTCOME; UNITED STATES;

EID: 84903765807     PISSN: 09337954     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00127-014-0824-1     Document Type: Article

References (26)

1. Carpenter WT, et al. (1978) Signs and symptoms as predictors of outcome: a report from the International Pilot Study of Schizophrenia. Am J Psychiatry 135(8):940-944
2. Wilson WH, Ban TA, Guy W (1986) Flexible system criteria in chronic schizophrenia. Compr Psychiatry 27(3):259-265 (Pubitemid 16068724)
3. Heinrichs DW, Cohen BP, Carpenter WT Jr (1985) Early insight and the management of schizophrenic decompensation. J Nerv Ment Dis 173(3):133-138 (Pubitemid 15138891)
4. Rosen K, Garety P (2005) Predicting recovery from schizophrenia: a retrospective comparison of characteristics at onset of people with single and multiple episodes. Schizophr Bull 31(3):735-750 (Pubitemid 41253322)
5. Schwartz RC, Cohen BN, Grubaugh A (1997) Does insight affect long-term impatient treatment outcome in chronic schizophrenia? Compr Psychiatry 38(5):283-288 (Pubitemid 27391592)
6. Smith CM, Barzman D, Pristach CA (1997) Effect of patient and family insight on compliance of schizophrenic patients. J Clin Pharmacol 37(2):147-154 (Pubitemid 27131546)
7. Osatuke K, et al. (2008) Insight in schizophrenia: a review of etiological models and supporting research. Compr Psychiatry 49(1):70-77 (Pubitemid 350186313)
8. David AS (1990) Insight and psychosis. Br J Psychiatry 156:798-808 (Pubitemid 20207090)
9. Hsiao FH, et al. (2006) Cultural attribution of mental health suffering in Chinese societies: the views of Chinese patients with mental illness and their caregivers. J Clin Nurs 15(8):998-1006 (Pubitemid 44049975)
10. Lauber C, Rossler W (2007) Stigma towards people with mental illness in developing countries in Asia. Int Rev Psychiatry 19(2):157-178 (Pubitemid 46676527)
11. Lam CS, et al. (2010) Chinese lay theory and mental illness stigma: implications for research and practices. J Rehabil 76:35-40
12. Mellor D, et al. (2012) Stigma toward mental illness: a cross-cultural comparison of Taiwanese, Chinese immigrants to Australia and Anglo-Australians. J Cross-Cult Psychol
13. Yang LH, et al. (2007) Culture and stigma: adding moral experience to stigma theory. Soc Sci Med 64(7):1524-1535 (Pubitemid 46349382)
14. Yang LH (2007) Application of mental illness stigma theory to Chinese societies: synthesis and new directions. Singapore Med J 48(11):977-985 (Pubitemid 351235248)
15. Yang LH, et al. (2013) Culture, threat, and mental illness stigma: identifying culture-specific threat among Chinese-American groups. Soc Sci Med 88:56-67
16. Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13(2):261-276 (Pubitemid 18039085)
17. Aggarwal NK, et al. (2011) Comparing the PANSS in Chinese and American inpatients: cross-cultural psychiatric analyses of instrument translation and implementation. Schizophr Res 132(2-3):146-152
18. Aggarwal NK, et al. (2012) Rater evaluations for psychiatric instruments and cultural differences: the positive and negative syndrome scale in China and the United States. J Nerv Ment Dis 200(9):814-820
19. Lieberman JA, et al. (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353(12):1209-1223 (Pubitemid 41345943)
20. Stroup TS, et al. (2003) The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr Bull 29(1):15-31 (Pubitemid 36871054)
21. First M. B, et al. (1995) Structured clinical interview for DSM-IV (SCID-I) (user's guide and interview) research version. Biometrics Research Institute, New York State Psychiatric Institute, New York
22. McEvoy JP, et al. (1989) Insight in schizophrenia. Its relationship to acute psychopathology. J Nerv Ment Dis 177(1):43-47 (Pubitemid 19043858)
23. Hogan TP, Awad AG, Eastwood R (1983) A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 13(1):177-183 (Pubitemid 13132147)
24. He Y, Zhang M (2000) The Chinese norm and factor analysis of PANSS. Chinese J Clin Psychol 2
25. Zhang J, et al. (1994) Clinical trial of insight and treatment attitude questionnaire (Zi zhi li yu zhi liao tai du wen juan de lin chuang shi yong). Shandong Arch Psychiatry [Shan dong jing shen wei sheng] 4:10-12
26. Mohamed S, et al. (1999) Insight in schizophrenia: its relationship to measures of executive functions. J Nerv Ment Dis 187(9):525-531 (Pubitemid 29449008)